Perhaps surprisingly, PhRMA now supports most aspects of health-care reform being mooted, from universal coverage to restructuring the insurance market.

• 也许令人惊讶的是，美国药品研究与制造商协会支持当前讨论的医改方案的大部分内容，从医保的普遍覆盖到重组保险市场。